Twist Bioscience (TWST) Long-Term Investments (2021 - 2026)

Twist Bioscience (TWST) has reported Long-Term Investments for 5 consecutive years, with $68.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Long-Term Investments rose 25.31% year-over-year to $68.1 million in Q2 2026; TTM through Jun 2026 was $68.1 million, a 25.31% increase from a year earlier, with the FY2025 full-year figure at $54.3 million, up 3463.08% from the prior year.
• Long-Term Investments was $68.1 million for Q2 2026 at Twist Bioscience, roughly flat from $68.1 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $68.1 million in Q1 2026 and troughed at $1.5 million in Q3 2024.
• A 4-year average of $47.3 million and a median of $54.3 million in 2025 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments surged 3463.08% in 2025 and grew 25.31% in 2026, its largest moves.
• Over 4 years, Long-Term Investments stood at $30.6 million in 2022, then slumped by 95.01% to $1.5 million in 2024, then surged by 3463.08% to $54.3 million in 2025, then gained by 25.31% to $68.1 million in 2026.
• The last three Long-Term Investments figures came in at $68.1 million (Q2 2026), $68.1 million (Q1 2026), and $54.3 million (Q4 2025), per Business Quant data.